 Pre-licensure studies of GSK Biologicals Boostrix have shown it to be generally safe and well-tolerated. This post-licensure study is designed to evaluate relatively uncommonrare outcomes in a large population cohort. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007. 